Preclinical and Clinical Evaluation of Magnetic-Activated Cell Separation Technology for CTC Isolation in Breast Cancer

Circulating tumor cell (CTC) count is an independent prognostic factor in early breast cancer. CTCs can be found in the blood of 20% of patients prior to neoadjuvant therapy. We aimed to assess the suitability of magnetic-activated cell separation (MACS) technology for isolation and cytological char...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozar, Taja, Jesenko, Tanja, Kloboves Prevodnik, Veronika, Cemazar, Maja, Hosta, Violeta, Jericevic, Anja, Nolde, Natasa, Grasic Kuhar, Cvetka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522616/
https://www.ncbi.nlm.nih.gov/pubmed/33042837
http://dx.doi.org/10.3389/fonc.2020.554554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522616/
https://www.ncbi.nlm.nih.gov/pubmed/33042837
http://dx.doi.org/10.3389/fonc.2020.554554

Ejemplares similares